PURPOSE: This pilot study aims to test the reliability and clinical validity of the assessment of cerebrovascular reactivity (CVR) with real-time blood-oxygen-level-dependent (BOLD) fMRI (rtCVR) in comparison with standard off-line processing in children with moyamoya disease. METHODS: Eight consecutive pediatric patients with moyamoya cerebral arteriopathy underwent BOLD fMRI CVR studies either on a 1.5-T or on a 3-T scanner with breath-holding techniques in six patients and under general anesthesia (GA) in three patients. One patient had undergone CVR study initially without and later with GA, and another had undergone CVR study before and after a revascularization procedure. The off-line and real-time processing of the data was done, and the results were compared for general quality and adequacy of the study (scale 0-3, 3 being the best) and for the presence or absence of abnormal reactivity and the location, pattern, and extent of abnormal reactivity. RESULTS: A total of 20 CVR series each was studied on real-time functional MRI and off-line analysis (eight patients, ten sessions, two series per session). All eight sessions done under GA were rated as quality class 3 (100 %), whereas only 5 of the 12 (41.7 %) studies with breath-holding technique were considered to be of best quality (class 3). In comparison to the off-line processing, the overall sensitivity of the rtCVR technique was 90 % with a specificity of 100 %. CONCLUSIONS: rtCVR assessment in children with moyamoya disease is feasible, and the results are comparable to that of standard off-line analysis. The results from off-line analysis are only available, at the earliest, several hours after the MRI has been completed. rtCVR can overcome this difficulty and may be equally reliable.
PURPOSE: This pilot study aims to test the reliability and clinical validity of the assessment of cerebrovascular reactivity (CVR) with real-time blood-oxygen-level-dependent (BOLD) fMRI (rtCVR) in comparison with standard off-line processing in children with moyamoya disease. METHODS: Eight consecutive pediatric patients with moyamoya cerebral arteriopathy underwent BOLD fMRI CVR studies either on a 1.5-T or on a 3-T scanner with breath-holding techniques in six patients and under general anesthesia (GA) in three patients. One patient had undergone CVR study initially without and later with GA, and another had undergone CVR study before and after a revascularization procedure. The off-line and real-time processing of the data was done, and the results were compared for general quality and adequacy of the study (scale 0-3, 3 being the best) and for the presence or absence of abnormal reactivity and the location, pattern, and extent of abnormal reactivity. RESULTS: A total of 20 CVR series each was studied on real-time functional MRI and off-line analysis (eight patients, ten sessions, two series per session). All eight sessions done under GA were rated as quality class 3 (100 %), whereas only 5 of the 12 (41.7 %) studies with breath-holding technique were considered to be of best quality (class 3). In comparison to the off-line processing, the overall sensitivity of the rtCVR technique was 90 % with a specificity of 100 %. CONCLUSIONS: rtCVR assessment in children with moyamoya disease is feasible, and the results are comparable to that of standard off-line analysis. The results from off-line analysis are only available, at the earliest, several hours after the MRI has been completed. rtCVR can overcome this difficulty and may be equally reliable.
Authors: G Fernández; A de Greiff; J von Oertzen; M Reuber; S Lun; P Klaver; J Ruhlmann; J Reul; C E Elger Journal: Neuroimage Date: 2001-09 Impact factor: 6.556
Authors: A Vesely; H Sasano; G Volgyesi; R Somogyi; J Tesler; L Fedorko; J Grynspan; A Crawley; J A Fisher; D Mikulis Journal: Magn Reson Med Date: 2001-06 Impact factor: 4.668
Authors: Michiel J de Boorder; Jeroen van der Grond; Alice J van Dongen; Catharina J M Klijn; L Jaap Kappelle; Peter P Van Rijk; Jeroen Hendrikse Journal: J Neurol Date: 2006-10-24 Impact factor: 4.849
Authors: David J Mikulis; Gregory Krolczyk; Hubert Desal; William Logan; Gabrielle Deveber; Peter Dirks; Michael Tymianski; Adrian Crawley; Alex Vesely; Andrea Kassner; David Preiss; Ron Somogyi; Joseph A Fisher Journal: J Neurosurg Date: 2005-08 Impact factor: 5.115
Authors: Daniel M Mandell; Jay S Han; Julien Poublanc; Adrian P Crawley; Jeff A Stainsby; Joseph A Fisher; David J Mikulis Journal: Stroke Date: 2008-05-01 Impact factor: 7.914
Authors: Emilie Sleight; Michael S Stringer; Ian Marshall; Joanna M Wardlaw; Michael J Thrippleton Journal: Front Physiol Date: 2021-02-25 Impact factor: 4.566